Clearance Summary
REXTAR X received FDA 510(k) clearance under submission number K132041, sponsored by Meta Biomed, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Dental review panel. The statutory decision date of record is 2013-07-31.
- Submission: K132041
- Applicant / Sponsor: Meta Biomed, Inc.
- Clearance pathway: Special
- Review panel: Dental
- Device class: Class II
- Regulation citation: 21 CFR 872.1800
- Decision date: 2013-07-31
Classification & Regulation
This clearance is catalogued under FDA product code EHD and 21 CFR 872.1800, within the Dental review panel as a Class II device.